CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation
Aftab Ullah,1 Kaikai Wang,1 Pengkai Wu,1 David Oupicky,1,2 Minjie Sun11State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, People’s Republic of China; 2Center for Drug Delivery and Nanomedicine, Department of Pharmaceutic...
Saved in:
Main Authors: | Ullah A, Wang K, Wu P, Oupicky D, Sun M |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/653270ca995544e8b92a78c7ff1145d1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENT AND VALIDATION OF SIMPLE, RAPID AND SENSITIVE UV, HPLC AND HPTLC METHODS FOR THE ESTIMATION OF PIRFENIDONE IN TABLET DOSAGE FORM
by: THORAT,S. G, et al.
Published: (2016) -
CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
by: Xue J, et al.
Published: (2020) -
Efecto del ácido alfa lipoico y la pirfenidona en la modulación antioxidante celular contra el daño oxidativo
by: Macias-Barragan,José, et al.
Published: (2014) -
Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis
by: Ullah A, et al.
Published: (2021) -
Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]
by: Ullah A, et al.
Published: (2021)